Immunodeficiency-associated renal Burkitt lymphoma
Paediatric acute lymphoblastic leukaemia mimicking Langerhans cell histiocytosis of bone
Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas
A clinician's guide to double hit lymphomas
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemia
Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone
Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B-cell lymphoma: mature results of a phase II multicentre study
Non-anaplastic peripheral T-cell lymphoma in children and adolescents – a retrospective analysis of the NHL-BFM study group
The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma
Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Diamond-Blackfan anaemia
Abnormal bone marrow histopathology in paediatric mastocytosis
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants
Deferasirox effect on renal haemodynamic parameters in patients with transfusion-dependent β thalassaemia
A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction
A phase 1 dose-escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma
GTF2I-RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid
Is the continued use of UK plasma sourced cryoprecipitate justified?
Is the continued use of UK plasma sourced cryoprecipitate justified? Response to Makris
Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding
Efficacy of 5-Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma
Bendamustine is effective in T-Cell prolymphocytic leukaemia
Erratum
ISFA 10th International Society for Apheresis Congress